Mid Cap · Financial · Insurance - Life
Mid Cap · Financial · Insurance - Life
Get the AI take on JXN
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
49/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Lowest
$130
Current price
$134.97
Median target
$137.5
Highest
$149
Forward P/E
Favorable · 72% below avg
4.59x
Price / sales
Strong · Priced modestly against the revenue it brings in
1.40x
Price / FCF
Strong · Priced well within what its cash flow supports
1.56x
EV / EBITDA
Rich · Operating earnings don't yet support this price
105.38x
ROIC
Weak · Struggling to earn much on the capital it uses
2.1%
ROE
Needs attention · Unfavorable
1.4%
Debt / equity
Favorable · 0.21 - strong leverage
0.55x
Current ratio
Strong · Comfortable room to cover bills due within a year
1.81x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $9.17B | 185.9 | +15.3% | 49 | |
| $192.11B | 20.2 | +20.3% | 81 | |
| $73.57B | 20.7 | +44.3% | 81 | |
| $11.82B | 17.4 | +45.4% | 79 | |
| $12.71B | 15.4 | +21.4% | 77 |